Tag: united therapeutics
October 16, 2018
United Therapeutics and MannKind Announce Closing of License and Collaboration Agreement
United Therapeutics (Nasdaq: UTHR) and MannKind (Nasdaq: MNKD) announced the closing of their pending worldwide exclusive license and collaboration agreement... April 30, 2018
United Therapeutics to Acquire SteadyMed
United Therapeutics (NASDAQ:UTHR) and SteadyMed (NASDAQ:STDY) announced today the signing of a definitive merger agreement under which United Therapeutics will... April 6, 2018
Sorrento and Celularity to Start Anti-CD38 CAR-T Phase 1 Clinical Trial in Patients With Relapsed or Refractory Multiple Myeloma
Sorrento Therapeutics (NASDAQ:SRNE) and Celularity announced today that the companies have started screening patients for its leading CD38 chimeric antigen... January 23, 2018
Cynata Executes MoU for Commercial Evaluation with Celularity
Australian stem cell and regenerative medicine company, Cynata Therapeutics (ASX:CYP), is pleased to announce that the Company has entered into a... April 6, 2017
Cardiome's Partner SteadyMed Completes Clinical Study
Cardiome Pharma (NASDAQ:CRME, TSX:COM) announced its partner SteadyMed Therapeutics (NASDAQ:STDY) successfully completed a clinical validation study of Trevyent.
January 4, 2017
Biotech Outlook 2017: After the Storm
Deep breaths, biotech investors. 2016 was a rough one—but the year ahead looks bright.
November 13, 2016